Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
European Urology|January 23, 2019
Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm TrialAxel Semjonow, Hans-Werner Hense, Kathrin Schlößler, et al.
Scientific Reports|December 7, 2021
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trialDorothee Tiedje, Matthias Borowski, Alexandra Simbrich, et al.
Ophthalmology|November 30, 2020
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK ConsortiumJohanna M Colijn, Magda Meester-Smoor, Timo Verzijden, et al.
Ophthalmology|June 20, 2020
Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration: The EYE-RISK Consortiumİlhan E Acar, Laura Lores-Motta, Johanna M Colijn, et al.
International Journal of Cardiology|August 15, 2009
A network against failing hearts--introducing the German "Competence Network Heart Failure"Felix Mehrhof, Markus Löffler, Götz Gelbrich, et al.
The British Journal of Ophthalmology|November 7, 2022
Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in EuropeansMatthias M Mauschitz, Timo Verzijden, Alexander K Schuster, et al.
European Journal of Epidemiology|December 22, 2015
Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortiumCécile Delcourt, Jean-François Korobelnik, Gabriëlle H S Buitendijk, et al.
Ophthalmology|October 14, 2018
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology ConsortiaJohanna M Colijn, Anneke I den Hollander, Ayse Demirkan, et al.
Pageof 10